-
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
16 Apr 2024 21:55 GMT
… interchangeability status by the FDA.
The FDA approval of SELARSDI, referred … defying portfolio, harnessing our generics expertise and stepping up innovation … Teva Pharmaceuticals at 1-888-483-8279 or FDA at 1 … -800-FDA-1088 or www.fda.gov…
-
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
16 Apr 2024 21:30 GMT
… interchangeability status by the FDA. The FDA approval of SELARSDI, referred … defying portfolio, harnessing our generics expertise and stepping up innovation … Teva Pharmaceuticals at 1-888-483-8279 or FDA at 1 … -800-FDA-1088 or www.fda.gov…
-
AAN 2024: AbbVie highlights long-term safety of atogepant in migraine prevention
17 Apr 2024 16:01 GMT
… was first approved by the FDA in 2021 for the preventive … they are widely available as generics and reimbursement of the newer …
-
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
17 Apr 2024 13:57 GMT
… and Drug Administration (FDA) approval of TriClip™, …
Nutrition
Diagnostics
Established
Pharmaceuticals
Medical Devices
U.S. … testing portfolios.
Established Pharmaceuticals
First Quarter 2024 Results … 's branded generics product portfolio. Sales …
-
3 big patent expirations in 2024 and how companies are pivoting
17 Apr 2024 13:13 GMT
… way to emerging competition from generics this year and beyond. But … in court to stave off generics.
Either way, it’s … , was first approved by the FDA in 2010 to treat Type … and Teva Pharmaceuticals — are planning to launch their own generics of liraglutide …
-
Reflections on Travel to Europe – Part One
16 Apr 2024 11:26 GMT
… range of topics—access, shortages, generics, post-market evidence and rare … look forward to the upcoming FDA-EU bilateral meeting at the … every day to advance the FDA’s mission in complex, and … the multidimensional priorities of the FDA, the rest of the foreign …
-
How Pharmacists Are Expanding Reproductive Care Access
15 Apr 2024 13:55 GMT
… after a ruling from the FDA to remove the in-person … abortion access gap?
Rafie: The FDA-imposed Risk Evaluation and Mitigation … linger despite Plan B and generics being OTC for people of …
-
Sensex Today Live Updates: Sensex jumps 460pts, Nifty at 22,300; Auto, IT, O&G, gain; Health, FMCG under pressure
18 Apr 2024 07:42 GMT
… to the marketing of Dash Pharmaceuticals' Diazepam Injection … s marketing partner, Amneal Pharmaceuticals launches non-small cell … inspection observations from US FDA for Goa facility
Sensex … the status change of Jubilant Generics' Roorkee facility …
-
Pharmacists warn about nationwide drug shortage impacting patients
18 Apr 2024 01:24 GMT
… CBS MoneyWatch. “Because the FDA says all generics are equal, the only … .
“The Food and Drug Agency (FDA)’s drug shortage mitigation tools …
-
BII, DPI and EBRD announce exit from KELIX bio
16 Apr 2024 11:38 GMT
… of Egypt’s leading generics pharmaceutical companies, exporting across … largest producers of generic pharmaceuticals. The platform also acquired … injectables at a US FDA and EMA approved manufacturing … and high-growth specialty generics assets, in high-demand …